FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4309457210> ?p ?o ?g. }

• W4309457210 endingPage "14258" @default.
• W4309457210 startingPage "14258" @default.
• W4309457210 abstract "Myeloablative therapy with highdoses of the cytostatic drug melphalan (MEL) in preparation for hematopoietic cell transplantation is the standard of care for multiple myeloma (MM) patients. Melphalan is a bifunctional alkylating agent that covalently binds to nucleophilic sites in the DNA and effective in the treatment, but unfortunately has limited therapeutic benefit. Therefore, new approaches are urgently needed for patients who are resistant to existing standard treatment with MEL. Regulating the pharmacological activity of drug molecules by modifying their structure is one method for improving their effectiveness. The purpose of this work was to analyze the physicochemical and biological properties of newly synthesized melphalan derivatives (EE-MEL, EM-MEL, EM-MOR-MEL, EM-I-MEL, EM-T-MEL) obtained through the esterification of the carboxyl group and the replacement of the the amino group with an amidine group. Compounds were selected based on our previous studies for their improved anticancer properties in comparison with the original drug. For this, we first evaluated the physicochemical properties using the circular dichroism technique, then analyzed the zeta potential and the hydrodynamic diameters of the particles. Then, the in vitro biological properties of the analogs were tested on multiple myeloma (RPMI8226), acute monocytic leukemia (THP1), and promyelocytic leukemia (HL60) cells as model systems for hematological malignant cells. DNA damage was assessed by immunostaining γH2AX, cell cycle distribution changes by propidium iodide (PI) staining, and cell death by the activation of caspase 2. We proved that the newly synthesized derivatives, in particular EM-MOR-MEL and EM-T-MEL, affected the B-DNA conformation, thus increasing the DNA damage. As a result of the DNA changes, the cell cycle was arrested in the S and G2/M phases. The cell death occurred by activating a mitotic catastrophe. Our investigations suggest that the analogs EM-MOR-MEL and EM-T-MEL have better anti-cancer activity in multiple myeloma cells than the currently used melphalan." @default.
• W4309457210 created "2022-11-28" @default.
• W4309457210 creator A5005230207 @default.
• W4309457210 creator A5011792459 @default.
• W4309457210 creator A5023689596 @default.
• W4309457210 creator A5025079728 @default.
• W4309457210 creator A5034160878 @default.
• W4309457210 creator A5055938573 @default.
• W4309457210 creator A5065249052 @default.
• W4309457210 date "2022-11-17" @default.
• W4309457210 modified "2023-09-25" @default.
• W4309457210 title "Newly Synthesized Melphalan Analogs Induce DNA Damage and Mitotic Catastrophe in Hematological Malignant Cancer Cells" @default.
• W4309457210 cites W118988577 @default.
• W4309457210 cites W1899697364 @default.
• W4309457210 cites W1963880514 @default.
• W4309457210 cites W1965109450 @default.
• W4309457210 cites W1967042727 @default.
• W4309457210 cites W1968647654 @default.
• W4309457210 cites W1997367417 @default.
• W4309457210 cites W1997961866 @default.
• W4309457210 cites W2008401436 @default.
• W4309457210 cites W2016599680 @default.
• W4309457210 cites W2017234953 @default.
• W4309457210 cites W2044804132 @default.
• W4309457210 cites W2055184223 @default.
• W4309457210 cites W2056588697 @default.
• W4309457210 cites W2068721082 @default.
• W4309457210 cites W2069168033 @default.
• W4309457210 cites W2071664483 @default.
• W4309457210 cites W2075349319 @default.
• W4309457210 cites W2081004136 @default.
• W4309457210 cites W2096996459 @default.
• W4309457210 cites W2128875480 @default.
• W4309457210 cites W2152812885 @default.
• W4309457210 cites W2157506986 @default.
• W4309457210 cites W2164660906 @default.
• W4309457210 cites W2176757944 @default.
• W4309457210 cites W2233961908 @default.
• W4309457210 cites W2236963384 @default.
• W4309457210 cites W2295739520 @default.
• W4309457210 cites W2331072277 @default.
• W4309457210 cites W2564390156 @default.
• W4309457210 cites W2593984201 @default.
• W4309457210 cites W2765433186 @default.
• W4309457210 cites W2770628948 @default.
• W4309457210 cites W2788280173 @default.
• W4309457210 cites W2795464319 @default.
• W4309457210 cites W2890458122 @default.
• W4309457210 cites W2914314704 @default.
• W4309457210 cites W2942050688 @default.
• W4309457210 cites W2950157870 @default.
• W4309457210 cites W2953995767 @default.
• W4309457210 cites W2955655463 @default.
• W4309457210 cites W2974871918 @default.
• W4309457210 cites W2977247800 @default.
• W4309457210 cites W3005042992 @default.
• W4309457210 cites W3011854067 @default.
• W4309457210 cites W3082287410 @default.
• W4309457210 cites W3110663007 @default.
• W4309457210 cites W3156485593 @default.
• W4309457210 cites W3158031655 @default.
• W4309457210 cites W3159410118 @default.
• W4309457210 cites W3189123402 @default.
• W4309457210 cites W3217035673 @default.
• W4309457210 cites W4200035410 @default.
• W4309457210 cites W4210814637 @default.
• W4309457210 cites W4220677938 @default.
• W4309457210 cites W4252520178 @default.
• W4309457210 cites W4293229309 @default.
• W4309457210 cites W4305014570 @default.
• W4309457210 doi "https://doi.org/10.3390/ijms232214258" @default.
• W4309457210 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36430734" @default.
• W4309457210 hasPublicationYear "2022" @default.
• W4309457210 type Work @default.
• W4309457210 citedByCount "0" @default.
• W4309457210 crossrefType "journal-article" @default.
• W4309457210 hasAuthorship W4309457210A5005230207 @default.
• W4309457210 hasAuthorship W4309457210A5011792459 @default.
• W4309457210 hasAuthorship W4309457210A5023689596 @default.
• W4309457210 hasAuthorship W4309457210A5025079728 @default.
• W4309457210 hasAuthorship W4309457210A5034160878 @default.
• W4309457210 hasAuthorship W4309457210A5055938573 @default.
• W4309457210 hasAuthorship W4309457210A5065249052 @default.
• W4309457210 hasBestOaLocation W43094572101 @default.
• W4309457210 hasConcept C104317684 @default.
• W4309457210 hasConcept C126322002 @default.
• W4309457210 hasConcept C185592680 @default.
• W4309457210 hasConcept C190283241 @default.
• W4309457210 hasConcept C203014093 @default.
• W4309457210 hasConcept C2775934118 @default.
• W4309457210 hasConcept C2776364478 @default.
• W4309457210 hasConcept C2776601000 @default.
• W4309457210 hasConcept C2776694085 @default.
• W4309457210 hasConcept C2776755627 @default.
• W4309457210 hasConcept C2777866208 @default.
• W4309457210 hasConcept C2778461978 @default.
• W4309457210 hasConcept C2778684742 @default.
• W4309457210 hasConcept C2781121885 @default.

• next